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Diabetes, cardiovascular disease, and chronic 
kidney disease in South Asia: current status 
and future directions
South Asians are more susceptible to diabetes and cardiovascular diseases and have worse 
outcomes than other ethnicities, say Anoop Misra, Tazeen Jafar, and colleagues. They 
call for urgent action to provide screening and treatment, complemented by population level 
lifestyle modifications.
A
ll South Asian countries have 
adopted the World Health Organi-
zation’s Global Action Plan for the 
Prevention and Control of 
Non-Communicable Diseases, 
which recommends a 25% relative reduction 
in the prevalence of raised blood pressure by 
2025 and a halt to the rise in diabetes and 
obesity. Although considerable diversity 
exists between countries, all South Asians 
have markedly elevated risks of diabetes and 
variably elevated risks of cardiovascular dis-
ease compared with other ethnicities.1 2 In 
this paper, we review the burden of diabetes, 
cardiovascular disease, and chronic kidney 
disease in the region and policies to mitigate 
this burden. We identify key actions for 
health authorities and governments to atten-
uate the rise in non-communicable diseases 
and meaningfully improve outcomes for the 
millions of people with, or expected to 
develop, these diseases.
Methods
We gathered data on characteristics of popu-
lations and health systems from publicly 
available World Bank reports and WHO’s 
country profiles. Information on death and 
disability from cardiovascular disease, dia-
betes, and chronic kidney disease and their 
attributable risk factors came from Health 
Metrics and Evaluation’s data visualisation 
tool of the Global Burden of Disease Study 
2015. We searched PubMed and Google 
scholar for relevant literature up to January 
2017, using the terms “South Asians”, “dia-
betes”, “cardiovascular disease”, “myocar-
dial infarction”, “stroke”, “renal”, and 
“kidney disease”. We formulated this paper 
by drawing from our collective experience in 
this field and the available literature.
Current epidemiology and trends
Cardiovascular disease, diabetes, and 
chronic kidney disease now account for 
27%, 4.0%, and 3.0% of deaths, respectively, 
in South Asia (table 1 ).3-6 Notwithstanding 
the limited quality and breadth of data, isch-
aemic heart disease is the leading cause of 
death in India, Pakistan, Nepal, and Sri 
Lanka, and stroke is the leading cause in 
Bangladesh.
The age standardised years of life lost as a 
result of cardiovascular disease has 
increased in South Asia in contrast to most 
other regions, where the reverse is true.5  In 
part, this is because cardiovascular disease 
events are more common in South Asia than 
in high income countries.7 8  Furthermore, 
acute myocardial infarction occurs six years 
earlier in South Asians than in European 
counterparts, probably owing to earlier onset 
of risk factors. Case fatality rates are higher 
in South Asia, especially in younger adults, 
thereby increasing the years of life lost.7 8 
Stroke and chronic kidney disease may also 
occur earlier in South Asians.9-11  The effect of 
lives lost due to premature cardiovascular 
disease is far worse in South Asia than else-
where, as more than half of the population 
lives in conditions of poverty.3
Susceptibility to diabetes, cardiovascular 
diseases, and chronic kidney disease
The region has experienced rapid demo-
graphic, epidemiological, environmental, 
and economic transitions. These, coupled 
with unhealthy lifestyles of physical inactiv-
ity and consumption of a calorie dense diet, 
have increased the risk of non- communicable 
diseases. In addition, social disparities, 
wealth inequalities, and conflicts in the 
region contribute to high rates of stress asso-
ciated behaviours including smoking.11 12 
Evidence from multi-country case-control 
studies indicates that hypertension, dyslipi-
daemia, smoking, obesity, diabetes, physical 
inactivity, low fruit and vegetable intake, and 
psychosocial stress attribute up to 90% of the 
population risk of cardiovascular disease in 
South Asians.13 14  Age standardised blood 
pressure and cholesterol levels and preva-
lence of diabetes have increased in South 
Asia over the past decades.15-17  High blood 
pressure and high blood glucose are the lead-
ing attributable risk factors for deaths from 
chronic kidney disease in every South Asian 
country (table 2).
Adverse metabolic factors are evident in 
South Asians at an early age. South Asian 
children have been shown to have adverse 
metabolic factors  (hyperinsulinaemia, dys-
lipidaemia) compared with British children 
of similar age and body mass index and 
higher blood pressure than white children in 
the US.18 19  Physical inactivity, dietary imbal-
ances, and increasing obesity amplify this 
(fig 1 ).20 21
South Asian adults have greater risks of 
cardiovascular disease and diabetes, both of 
which tend to manifest around 5-10 years 
earlier than in white Europeans.10  The risk of 
cardiovascular disease is independent of 
that predicted by established risk factors. 
Possible mechanisms, among others, 
include an atherogenic dyslipidaemia driven 
by high concentrations of triglycerides and 
low concentrations of high density lipopro-
tein cholesterol, a pro-coagulant tendency, 
and higher concentrations of inflammatory 
cytokines.22 Further work is needed to define 
mechanisms for this excess cardiovascular 
disease risk. The risk factors vary by socio-
economic strata, geographical region, and 
migration.
Of particular importance, South Asian 
adults are more insulin resistant at any given 
body mass index and may experience more 
KEY MESSAGES
South Asians are more likely than 
other ethnicities to develop diabetes, 
cardiovascular disease, and chronic kidney 
disease, and these often have an earlier 
onset and poor outcomes
Strategies for early diagnosis and 
treatment including awareness generation, 
opportunistic screening, availability of 
low cost drugs, and task shifting to health 
workers must be prioritised
Countries must consider taxation 
on unhealthy foods, restrictions on 
advertising, and appropriate food labelling
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rapid β cell failure.2  They may progress more 
rapidly from a state of high risk of diabetes 
to frank diabetes and may have accelerated 
microvascular damage, with evidence of ear-
lier diabetic nephropathy and retinopathy.2
Effects of poor and inconsistent treatment
Significant treatment gaps exist in South 
Asian populations. Studies report that less 
than half of all people with hypertension 
have received a diagnosis or treatment and 
less than a third have their blood pressure 
controlled with drugs.23-25  The rates of diabe-
tes awareness (50%), glycaemic control 
(<30%), and chronic kidney disease aware-
ness (<15%) are suboptimal.24- 28
Delay or prevention of diabetes in South 
Asians will require earlier intervention—that 
is, at lower levels of glycaemia. This requires 
wider testing and earlier use of antihypergly-
caemic treatment, complemented with pop-
ulation-wide strategies to drive change in 
dietary habits and physical activity. Although 
antihypertensive, antidiabetic, and lipid low-
ering drugs are part of WHO’s list of essential 
medicines, availability in government pri-
mary care facilities is poor and patients must 
often pay out of pocket for these drugs. Social 
insurance schemes in countries are not avail-
able to the majority of the population,29 30 
and they tend to cover hospital based treat-
ment and do not provide for standardised 
screening and medical management of these 
conditions in primary care.
Under-diagnosis and under-treatment result 
in higher rates of myocardial infarction and 
stroke, with adverse outcomes due to poor 
access to standardised and affordable treat-
ment. Most patients with acute ischaemic heart 
disease are brought to the hospital too late to 
qualify for reperfusion therapy.31  Management 
in primary care is less than satisfactory, and 
many patients do not receive appropriate drugs 
owing to gaps in the knowledge and practices 
of healthcare providers.32-34  The situation is 
much worse in rural areas, where an acute 
event is more likely to be fatal.31 35
Health policies are not geared to respond to 
the rising challenge
Non-communicable diseases have been a 
recent addition to the policy agenda in all 
South Asian countries. Public health expen-
diture varies across countries, but overall 
investment is insufficient to support services 
for the prevention and management of car-
diovascular disease, diabetes, and chronic 
kidney disease (table 3 ).36 Implementation 
has been slow owing to donor agencies hav-
ing limited interest in investing in non-com-
municable diseases and lack of engagement 
between governments and professional 
organisations in this field.
Table 2 | Age standardised deaths from chronic kidney disease (CKD) and major attributable risk 
factors in South Asia3
Bangladesh India Pakistan Nepal Sri Lanka
Age standardised CKD death rate5
Rate per 100 000 21.78 38.87 18.66 24.27 22.54
% of total deaths 2.2 3.4 1.6 2.4 3.6
Risk factor attributions for CKD
Systolic blood pressure, % 67.4 69.4 70.5 73.9 83.1
Fasting blood glucose, % 54.4 59.4 56.1 54.5 47.8
High body mass index, % 11.0 14.5 23.7 16.6 18.6
Life course considerations
Maternal nutrition       calorie dense child diet/physical inactivity       rural-urban migration       adverse lifestyles
Social, political, and healthcare considerations
Poverty
Social class/caste
Female emancipation
Education
Rural develpoment
Built environment
Food and taxation policies
Public health
Maternal child health
Targeted screening
   access blood pressure
  and cholesterol drugs
Mass campaigns
Access to healthcare
Fetal growth retardation
Lower birth weights
Less lean mass and
  greater fat mass
  lifelong
Insulin resistance
  phenotype
Potentially less β cells
  capacity
Weight gain,
raised blood pressure,
lower activity levels,
insulin resistance
   diabetes and at lower
  body mass indexes
   cardiovascular disease
  at younger ages
   chronic kidney disease
  at younger ages
Intergenerational
cycles of high risk
phenotype
Fig 1 | Interacting risk pathways contributing to higher risks of diabetes and cardiovascular disease 
(CVD) in South Asians, acting over the life course. This begins with poor maternal nutrition and 
adverse programming, with neonates born at lower average birth weights yet higher fat to lean 
mass ratios compared with white children. This phenotype worsens over time, with greater weight 
gain and lower activity levels in South Asian children and adults, leading, in turn, via greater 
insulin resistance and CVD risk factors, to higher rates of diabetes and CVD, respectively. The 
parallel societal, political, and health considerations, as well as life course considerations, are 
also shown. BMI=body mass index; BP=blood pressure; CKD=chronic kidney disease
Table 1 | Population characteristics and burden of cardiovascular diseases and diabetes in South Asia
Bangladesh India Nepal Pakistan Sri Lanka
Population characteristics 34
Population (millions) 161.9 1311.0 28.5 189.0 21.0
Rural population, % 65.7 67.3 81.4 61.2 81.6
Life expectancy at birth, years 71.6 68 69.6 66.2 74.8
Population living on <$3.10/day PPP, % NA 58.1 48.3 45.0 14.0
Overweight/obese (BMI ≥25; ≥18 years), age standardised % 18.1 22.0 18.0 23.0 25.2
Hypertension (≥18 years), age standardised % 25.7 25.4 26.4 26.6 21.2
Diabetes, age standardised % 9.2 8.3 9.5 12.1 7.6
Age standardised CVD and diabetes death rates5
CVD death rate per 100 000 363.9 352.6 295.2 530.9 239.9
CVD death rate, % of total deaths 36.5 30.4 29.6 44 38.0
Ischaemic heart disease, % of all deaths in 2015 15.9 17.6 17.4 28.4 20.8
Stroke, % of all deaths in 2015 18.3 8.9 8.8 11.6 12.8
Diabetes death rate per 100 000 in 2015 67.1 43.3 35.7 53 50.9
Diabetes death rate, % of total deaths 6.7 3.7 3.6 4.4 8.1
BMI=body mass index; CVD=cardiovascular disease; PPP=purchasing power parity.
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In India, the National Programme for Pre-
vention and Control of Cancer, Diabetes, CVD 
and Stroke has piloted opportunistic screening 
of risk factors for non-communicable diseases 
for people over 30 years of age. Furthermore, as 
part of the national health mission, the Indian 
government has outlined an operational plan 
for universal screening for hypertension and 
diabetes.31  A model of opportunistic screening 
for diabetes in patients with tuberculosis is 
being evaluated in Sri Lanka.37  Examples of 
successful public-private partnerships for 
non-communicable disease healthcare in the 
region are limited. Pakistan’s National Action 
Plan for Non-communicable Diseases is one 
such model,38 which involved a tripartite col-
laboration with Heartfile, a not for profit organ-
isation, in formulation of policy and 
implementation in partnership with the gov-
ernment and WHO.
Recommendations
Progress towards the targeted reductions in 
death and disability from cardiovascular dis-
ease, diabetes, and chronic kidney disease 
would not be possible without concerted, 
multi-sectoral efforts by various government 
entities and non-government partners. We 
recommend the following essential policy 
and health system interventions.
Implementation of taxes on unhealthy foods
A tax of 20% on sugar sweetened drinks in 
India is projected to reduce the prevalence 
of overweight and obesity by 3.0% (95% 
confidence interval 1.6% to 5.9%) and the 
incidence of type 2 diabetes by 1.6% (1.2% 
to 1.9%) over the period 2014-23, assuming 
that consumption increases in line with 
current trends.39  In Mexico, an excise tax 
of 10% on sugar sweetened drinks 
decreased consumption by an average of 
6% over one year.40  The Indian state of 
Kerala recently announced a “fat tax” on 
pizzas, burgers, sandwiches, and tacos 
sold through branded food outlets.41 Such 
strategies must be adopted in cities of 
South Asia that experience widespread 
marketing and consumption of unhealthy 
fast foods.
Furthermore, a 20% tax on palm oil pur-
chases in India is projected to avert 
approximately 363 000 (95% confidence 
interval 247 000 to 479 000) deaths from 
myocardial infarctions and strokes over 
the period 2014-23 (1.3% reduction in car-
diovascular deaths).42  Palm oil is con-
sumed widely in low and middle income 
countries. It is high in saturated fat and 
causes a large increase in cholesterol con-
centrations. Empirical data from Mauritius 
show a reduction of 1 mmol/L in choles-
terol concentrations through substitution 
of palm oil with soya oil.43  This reduction 
in cholesterol and low density lipoprotein 
cholesterol would equate to a 22% lower 
risk for cardiovascular disease, a huge 
effect by any standards.44
Strengthening of health system capacity 
to deliver care for non-communicable 
diseases
Strengthening of health systems and a well 
designed quality of care improvement 
framework are essential for concerted efforts 
to manage hypertension and diabetes for 
prevention of cardiovascular disease and 
chronic kidney disease. Shifting manage-
ment of chronic diseases and risk factors 
from doctors to community healthcare work-
ers holds promise and is being tested in rural 
areas in South Asia.34  Studies from Pakistan 
and India have shown that involving trained 
health workers in home health education on 
diet and physical activity and training gen-
eral practitioners led to earlier diagnosis 
and better management of patients with 
hypertension or diabetes, and it was also 
cost effective.45-47 Scaling up similar models 
is likely to offer substantial reductions in 
cardiovascular disease and chronic kidney 
disease in the medium to long term.
Screening populations at high risk (such 
as people who are sedentary, overweight, or 
smokers; those with hypertension; those 
with a family history of diabetes or prema-
ture cardiovascular disease in first degree 
relatives; and women with a history of gesta-
tional diabetes) is essential for early diagno-
sis. Low cost strategies such as validated 
simple screening questionnaires, blood 
pressure measurement, and, if possible, 
fasting or random blood glucose 
Table 3 | Characteristics of health systems and policies for management of cardiovascular diseases and diabetes in South Asia
Bangladesh India Nepal Pakistan Sri Lanka
Healthcare system
Health expenditure per capita PPP, 
$Int
88.1 267.4 137.4 129 369.2
Health expenditure as % of GDP 2.8 4.7 5.8 2.6 3.5
NCDs in local healthcare infrastructure4
Surveillance and monitoring of NCDs 
or risk factors
Mostly ad hoc sub-
national surveys; 
nationally representative 
surveillance conducted in 
2011 (none since then)
Mostly ad hoc 
sub-national surveys
Nationally 
representative 
surveillance 
conducted in 2013; 
no serial monitoring
Mostly ad hoc 
sub-national surveys; 
nationally representative 
surveillance conducted 
during 1990-94 (none 
since then)
Mostly ad hoc 
sub-national surveys
NCD unit or department. in Ministry 
of Health (as of 2013)
Yes Yes Not known Yes (tobacco control unit 
only)
Yes
Existence of operational policy/
strategy/action plan for CVD (as of 
2013)
Yes Yes No No Yes
National/provincial NCD policy National Communication 
and Action Plan for 
reducing NCD high risk 
behaviours 2014-16
National Programme For 
Prevention and Control 
of Cancer, Diabetes, 
Cardiovascular Disease 
and Stroke
Multi-sectoral Action 
Plan for the 
Prevention and 
Control of 
Non-Communicable 
Diseases (2014-20)
National Action Plan for 
Prevention and Control 
of Non-Communicable 
Diseases and Health 
Promotion in Pakistan 
2004
National policy and 
strategic framework 
for prevention and 
control of chronic 
non-communicable 
diseases 2009
Local hypertension treatment 
guidelines
No local guidelines 2013 Indian guidelines 
on hypertension by the 
Association of Physicians 
of India
No local guidelines Pakistan Hypertension 
League 1998
Health Sector 
Development Project 
2007
Local diabetes management 
guidelines
Guidelines for care of type 
2 diabetes in Bangladesh 
2003
Indian Council of Medical 
Research guidelines for 
management of type 2 
diabetes, 2005
No local guidelines No local guidelines Ministry of Sri Lanka 
diabetes management 
guidelines, 2011
NCD as line item in health budget Not as main line item; however, recent addition in other programme categories Yes, as main line item 
since 2011
CVD=cardiovascular disease; GDP=gross domestic product; NCD=non-communicable diseases; PPP= purchasing power parity.
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 measurement, urinary dipstick for protein, 
and non-fasting cholesterol measurement, 
may be used. Although the cost effectiveness 
of opportunistic screening compared with 
universal screening is likely to vary accord-
ing to the characteristics of the population, 
its value cannot be overstated for countries 
with a high prevalence of diabetes.48
Making antihypertensives, statins, and 
diabetes drugs available for free or at low 
cost in primary healthcare centres should be 
prioritised. This is consistent with achieve-
ment of universal health coverage, including 
access to quality and affordable essential 
medicines for all, as advocated in the United 
Nations’ sustainable development goals.49 
High quality generic drugs produced in the 
region can help to make this sustainable. 
Fixed dose drug combinations may improve 
coverage and long term adherence in people 
with established disease, but their wide-
spread use in primary prevention is still 
debated.50  Health insurance reforms must 
provide for screening and primary care for 
these conditions to reduce out of pocket 
expenditure.51
Evidence is growing for m-health (mobile 
health technologies) interventions in 
improving adherence to treatment, main-
taining appointments, data collection, and 
supporting health workers.52  More than 80% 
of the population of South Asia have mobile 
phones, and a large majority of villages are 
connected with mobile technology.53 This 
platform should be strongly considered in 
risk communication strategies and integra-
tion of care delivery for non-communicable 
diseases where feasible.
Public-private partnerships for non-com-
municable disease care should be encour-
aged to provide for unmet needs. Setting 
standards for long term public sector 
engagement; having transparent goals, 
inputs, and expectations; good governance 
of costs and fair allocation of profits; a 
shared vision and trust; and agreed pro-
cesses for negotiation on common interests 
of partners are crucial to their success. The 
Sindh Institute of Urology and Transplanta-
tion in Karachi, Pakistan, providing dialysis 
services, and Aravind Eye Care System in 
India are good examples of successful pub-
lic-private partnerships in the region.54  55
Consideration of population based 
strategies to promote a healthy lifestyle
Community based interventions to promote 
a healthy diet and physical activity and 
reduce smoking and stress will go a long way 
in delaying the onset of these diseases. The 
Indian Diabetes Prevention Program, and 
more recently the D-CLIP study, showed the 
effectiveness of lifestyle intervention in 
reducing the development of diabetes in 
people at high risk, while concurrently tack-
ling problems with community acceptability 
and long term sustainability.56 57
School health programmes, encouraged 
by WHO to inform children about risk factors 
for non-communicable diseases and pro-
mote physical activity, have been hindered 
by low education budgets and poor infra-
structure. There are no restrictions on adver-
tising unhealthy food to minors.58 Such 
legislation must be complemented with 
multi-sectoral action including involvement 
of schools and workplaces to influence diet 
and physical activity.
Investment in surveillance and research
Surveillance and monitoring are critical to 
raise awareness and inform policy and 
implementation. Although the WHO STEPS 
instrument (www.who.int/chp/steps/instru-
ment/en/) for collecting data on risk factors 
for non-communicable diseases has been 
used in community based studies in South 
Asia, national implementation is lacking.59 
All South Asian countries must institution-
alise risk factor surveillance and establish 
robust cardiovascular disease, diabetes, and 
chronic kidney disease registries to track 
trends and monitor progress. Surveillance 
data must be shared publicly to create 
awareness.
Evidence on effective interventions to pre-
vent and control non-communicable dis-
eases in the region is very limited. The effect 
of school, workplace, and community based 
interventions must be evaluated. Research 
comparing single versus multiple risk factor 
screening, as well as opportunistic and tar-
geted screening versus universal screening 
in all adults, will help to tailor screening 
strategies. Policy initiatives such as taxes 
and diet substitution must be rigorously 
evaluated for their feasibility and impact at a 
population level.
Conclusion
Capacity building, financing, and a strong 
quality assurance framework are crucial for 
the effectiveness, scalability, and long term 
sustainability of initiatives to curb non-com-
municable diseases in the South Asia region.
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